REVENUE GROWTH

CPH is targeting US growth through M&A - Seeking a CEO

Next Investors Oct 25, 2021

Today Creso Pharma’s (ASX:CPH) announced the acquisition of a range of CBD brand and product assets that deliver anti-inflammatory relief to professional and amateur athletes suffering from chronic muscle and joint pain.

ONE announces US $2.4M contract, leveraging Samsung and Microsoft partnerships

Next Investors Oct 20, 2021

Today Oneview Healthcare (ASX:ONE) announced a material new 5 year contract for 235 hospital beds worth $2.4M USD, with USA based hospital Kingman, using ONE new cloud offering, as the first deal under the Microsoft co-sell agreement AND using Samsung tablets.

Should you get a Life ... 360?

Finfeed Archived Jun 11, 2021

Over the last 12 months, Life360 (ASX: 360) has achieved 20 per cent revenue growth year on year despite COVID-19, which has seen its share price rise over 300 per cent to a new all-time high this week of $6.49 with many analysts promoting the stock as a strong buy.

Revenues up 237%: Creso Pharma delivers strong quarter ahead of OTC listing

Finfeed Archived Apr 30, 2021

There were several highlights to come out of the quarterly report released by Creso Pharma (ASX: CPH) today. CPH is enjoying a sustained run this year with revenues up 237% in the lead up to its US listing, which is expected to occur in the coming weeks.